期刊
BLOOD
卷 112, 期 10, 页码 3917-3918出版社
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2008-08-175026
关键词
-
类别
In this issue of Blood, Paiva and colleagues report that MFC performed on bone marrow examinations on day 100 after autotransplantation and intended to provide a measure of MRD in multiple myeloma distinguished patients with strikingly different progression-free and overall survival, independent of standard baseline prognostic variables and IFx-defined CR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据